INCY Incyte PE ratio, current and historical analysis

As of Apr 2, 2025, the Incyte stock's PE ratio is 389.56. This results from the current EPS of $0.16 and stock price of $62.33. The P/E ratio has an increase of 56% from the past four quarters average of 249.3.

INCY PE ratio history

How has INCY's PE ratio performed in the past

The PE ratio of Incyte has averaged 247.46 over the last ten years. The current PE ratio of 389.56 is 57% above the historical average. In the past ten years, INCY's PE ratio was at its highest in the Dec 2015 quarter at 2,711.25, when the stock price was $108.45 and the EPS was $0.04. The lowest value was in the Sep 2022 quarter, when it reached 16.83 with a price of $66.64 and an EPS of $3.96.

Today
390.19
Average
247.46
Median
52.5
Minimum
16.83
Maximum
2,711.25

Incyte PE ratio by year

Maximum annual increase: 1,735.42% in 2024

Maximum annual decrease: -93.28% in 2016

Year PE ratio PE change Price EPS
2024 431.69 1,735.42% $69.07 $0.16
2023 23.52 -55.2% $62.79 $2.67
2022 52.5 207.56% $80.32 $1.53
2021 17.07 N/A $73.4 $4.3
2020 N/A N/A $86.98 -$1.36
2019 41.98 -65.67% $87.32 $2.08
2018 122.29 N/A $63.59 $0.52
2017 N/A N/A $94.71 -$1.53
2016 182.31 -93.28% $100.27 $0.55
2015 2,711.25 N/A $108.45 $0.04
2014 N/A N/A $73.11 -$0.29
2013 N/A N/A $50.63 -$0.56
2012 N/A N/A $16.61 -$0.34
2011 N/A N/A $15.01 -$1.49
2010 N/A N/A $16.56 -$0.26

Incyte PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 431.69 11.03% $69.07 $0.16
Sep 2024 388.82 143.73% $66.1 $0.17
Jun 2024 159.53 832.38% $60.62 $0.38
Mar 2024 17.11 -27.25% $56.97 $3.33
Dec 2023 23.52 -23.06% $62.79 $2.67
Sep 2023 30.57 -19.47% $57.77 $1.89
Jun 2023 37.96 -23.31% $62.25 $1.64
Mar 2023 49.5 -5.71% $72.27 $1.46
Dec 2022 52.5 211.94% $80.32 $1.53
Sep 2022 16.83 -5.4% $66.64 $3.96
Jun 2022 17.79 -5.47% $75.97 $4.27
Mar 2022 18.82 10.25% $79.42 $4.22
Dec 2021 17.07 -39.68% $73.4 $4.3
Sep 2021 28.3 -48.2% $68.78 $2.43
Jun 2021 54.63 47.21% $84.13 $1.54

INCY average PE ratio chart

What is the average PE ratio of INCY for the past years

Currently, INCY's PE ratio is greater than its 3, 5 and 10-year historical averages.

3-year avg
111.44
5-year avg
86.36
10-year avg
247.46
15-year avg
247.46

INCY PE vs peers

What is INCY's PE ratio compared to its peers

INCY's PE ratio is higher than its peer stocks LLY and NVS. Incyte's current PE ratio of 389.56 is comparable to the average of its peer group, which is 36.45.

Stock name PE ratio Market cap
PFE Pfizer Inc 17.3 $139.22B
NVS Novartis AG 19.05 $222.73B
AMGN Amgen Inc 40.53 $165.93B
LLY ELI LILLY & Co 67.94 $757.57B
INCY Incyte Corp 390.19 $12.08B
LGND Ligand Pharmaceuticals Inc N/A $2.03B
ARDX Ardelyx Inc N/A $1.14B
GERN Geron Corp N/A $933.07M

Frequently asked questions

What is Incyte's PE ratio?

INCY stock has a price to earnings ratio of 389.56 as of Apr 2, 2025.

What is the 3-year average PE ratio for Incyte (INCY)?

As an average over the last 3 years, INCY stock has a PE ratio of 111.44.

What is the 5-year average PE ratio for Incyte (INCY)?

As an average over the last 5 years, INCY stock has a PE ratio of 86.36.

What is the highest PE ratio for INCY?

Over the last ten years, the quarterly PE ratio reached a historic high of 2,711.25 in the Dec 2015 quarter.

How does the current PE ratio for INCY compare to its historical average?

INCY's price to earnings ratio is currently 57% above its 10-year historical average.

Why is Incyte's PE ratio so high?

INCY's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.

How is INCY's PE ratio calculated (Incyte PE ratio formula)?

You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Apr 2, 2025), Incyte's stock price is $62.33. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.16. Therefore, Incyte's P/E ratio for today is 389.56. PE RATIO(389.56) = STOCK PRICE($62.33) / TTM EPS($0.16)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.